Overview

Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
To study the efficacy of Alimta as a single agent in thymic cancers
Phase:
Phase 2
Details
Lead Sponsor:
Patrick Joseph Loehrer Sr.
Treatments:
Pemetrexed